Novavax, Inc. (NASDAQ:NVAX) Q4 2025 Earnings Call Transcript February 26, 2026
Novavax, Inc. beats earnings expectations. Reported EPS is $0.1013, expectations were $-0.66.
Operator: Good morning, and welcome to Novavax’s Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Luis Sanay, Vice President, Investor Relations. Please go...
